By Daniel Akselrod · Licensed Attorney · July 2026

Intake Forms for Urology Practices: Urinary Symptoms, Sexual Health, and Cancer Screening Documentation

A forty-seven-year-old man sits in a urology waiting room and fills out a generic medical intake form. It asks about his current medications, surgical history, allergies, and the reason for his visit. He writes "urinary issues" in the chief complaint line and hands the clipboard back. The urologist walks in ten minutes later and spends the first half of the appointment asking the questions the form should have already covered. How often does he urinate at night? Has he noticed blood in his urine? Does he have trouble starting his stream? Has he experienced erectile dysfunction? Has anyone in his family had prostate cancer? The patient answers each question separately, growing visibly uncomfortable as the conversation shifts to sexual function, and the urologist makes mental notes while trying to maintain the clinical rapport that the intake process just failed to establish.

This is the fundamental problem with generic intake forms in urology. The specialty covers urinary tract function, sexual health, reproductive medicine, and oncology screening across both male and female patients, and it does so in symptom categories that patients find deeply personal, often embarrassing, and frequently difficult to discuss out loud. A structured, urology-specific intake form does not just save time. It normalizes the questions. When a patient sees a printed field that asks about erectile function or incontinence episodes, the question becomes a standard part of the medical process rather than a personal interrogation. That shift in framing changes what patients disclose, and what patients disclose changes the quality of the care they receive.

Urinary symptom assessment: the IPSS framework belongs on the intake form

The International Prostate Symptom Score, also known as the AUA Symptom Index, is the gold standard for quantifying lower urinary tract symptoms in men, and there is no good reason for it to live exclusively in the clinical note rather than on the intake form. The IPSS asks seven questions — incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia — and scores each on a scale from zero to five based on how often the symptom occurs. The resulting score (zero to thirty-five) stratifies patients into mild, moderate, and severe categories and gives the urologist a quantified baseline before the examination begins.

Building the IPSS into the intake form accomplishes several things simultaneously. It gives the patient time to think about each symptom carefully rather than answering on the spot during a face-to-face conversation. It produces a numeric baseline that can be tracked across visits to measure treatment response. It flags patients who score in the severe range for expedited evaluation. And it documents the severity assessment in a format that insurers and peer reviewers recognize as a validated clinical instrument, which matters when prior authorization for procedures like transurethral resection or laser enucleation requires documented symptom severity.

Beyond the IPSS, the urinary symptom section needs to capture hematuria with enough specificity to drive the workup. A checkbox that says "blood in urine" is not clinically useful. The form needs to distinguish between gross hematuria and microscopic hematuria detected on urinalysis, whether the blood appears at the beginning, end, or throughout the stream, whether it is associated with pain or is painless, and whether it has been a single episode or recurrent. Painless gross hematuria in a sixty-year-old is bladder cancer until proven otherwise, and the documentation trail for that workup starts at intake. The form should also capture irritative symptoms like dysuria and suprapubic pain separately from obstructive symptoms, because the two categories point toward different differential diagnoses and different initial evaluations.

Sexual health documentation: structured forms ask what patients will not volunteer

Sexual health is the area where the gap between what a generic form captures and what a urology practice needs is widest. Most patients will not voluntarily bring up erectile dysfunction, ejaculatory problems, decreased libido, or concerns about fertility. They will wait for the physician to ask, and if the physician does not ask — because the visit was scheduled for a kidney stone follow-up or a PSA recheck — the sexual health concern goes unaddressed for another six months or another year. A structured intake form removes that barrier entirely. When the patient sees fields for erectile function, the question is simply part of the standard documentation process, and the stigma of raising the topic evaporates.

The erectile dysfunction section needs more than a yes-or-no field. It should capture onset (gradual versus sudden, because sudden onset suggests a psychogenic or vascular event rather than the gradual hormonal or atherosclerotic decline that accounts for most cases), duration, whether erections are achievable but not maintainable or absent entirely, whether nocturnal or morning erections are preserved (their presence suggests the vascular and neurological mechanisms are intact and points toward a psychogenic component), and what treatments have been tried. Patients who have already used PDE5 inhibitors and found them ineffective represent a different clinical population than treatment-naive patients, and the urologist needs to know this before walking into the room.

Ejaculatory concerns deserve their own section rather than being buried under a general sexual function heading. Premature ejaculation, delayed ejaculation, retrograde ejaculation, painful ejaculation, and hematospermia are distinct clinical entities with different etiologies and different workups. Retrograde ejaculation in a diabetic patient points toward autonomic neuropathy. Painful ejaculation raises concern for prostatitis or seminal vesicle pathology. Hematospermia in a man over forty warrants evaluation for prostate or seminal vesicle pathology. A single "any ejaculatory concerns?" checkbox collapses all of these into a single undifferentiated data point that the physician then has to unpack verbally.

Fertility assessment at intake is critical for male patients of reproductive age. The form should capture whether the patient is currently trying to conceive, how long he has been trying, whether a semen analysis has been performed, whether his partner has been evaluated, and whether he has fathered children previously. It should also flag medications and exposures that affect fertility — testosterone supplementation (which suppresses spermatogenesis and is one of the most common iatrogenic causes of male infertility), anabolic steroids, chemotherapy history, and occupational heat exposure. STI history rounds out the sexual health section: prior gonorrhea, chlamydia, syphilis, herpes, HPV, and HIV status, along with treatment history and any known complications such as urethral stricture from prior gonococcal infection.

Prostate health and cancer screening: PSA trends matter more than single values

A single PSA value is a data point. A series of PSA values over time is a clinical story. The urology intake form needs to capture not just the most recent PSA level but the trajectory — prior values with dates, the rate of change (PSA velocity), and whether prior elevations triggered additional workup. A PSA that has risen from 1.2 to 2.8 over two years in a fifty-five-year-old man tells a very different story than a stable PSA of 4.1 that has been unchanged for five years. The velocity matters more than the absolute number in many clinical scenarios, and the intake form is where that longitudinal data gets consolidated into a single document.

Digital rectal examination findings from prior visits should be documented at intake as well. A nodule that was noted by the referring physician, an asymmetry in prostate size, or a change in consistency from a prior exam — these findings travel poorly between providers unless they are captured in a structured format. The intake should also ask about prior prostate biopsies: how many, when, what the pathology showed (benign, atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, or cancer with Gleason score), and whether the patient is on active surveillance for a previously diagnosed low-grade cancer. Family history of prostate cancer needs to be specific — not just "any family history of cancer" but which first-degree relatives were diagnosed, at what age, and whether the cancer was aggressive or indolent. A man whose father and brother were both diagnosed with prostate cancer before age sixty has a risk profile that demands a different screening strategy than a man with no family history, and that risk stratification starts at intake.

The healthcare intake forms in our catalog are built to capture this kind of longitudinal clinical data in a format that integrates into the patient record from the first visit, rather than requiring the physician to reconstruct it through interview.

Kidney stone history: composition, recurrence, and metabolic risk

Kidney stones are one of the most common reasons patients present to a urology practice, and the stone history section of the intake form needs to go well beyond "have you had kidney stones." Recurrence drives the entire management strategy. A patient with a single calcium oxalate stone five years ago needs different counseling and follow-up than a patient with four episodes of uric acid stones in the last three years. The intake should capture the number of stone episodes, the dates and affected sides, whether stones passed spontaneously or required intervention (and what type — shockwave lithotripsy, ureteroscopy, or percutaneous nephrolithotomy), and stone composition if analysis was performed. Composition dictates dietary recommendations, metabolic workup priorities, and pharmacologic prevention strategies, and many patients know their stone type from prior analyses even if the records are not immediately available.

Imaging history matters for stone patients because it establishes the baseline burden. A patient who had a CT scan six months ago showing a seven-millimeter non-obstructing lower pole stone needs surveillance imaging, not a diagnostic workup from scratch. The intake should ask about the most recent imaging study, its date, and what it showed. Dietary risk factors warrant their own section: daily fluid intake (in approximate volume, not just "adequate" or "inadequate"), sodium consumption patterns, animal protein intake, oxalate-rich food consumption (spinach, nuts, chocolate, tea), calcium supplementation practices, and whether the patient has been on a stone prevention diet previously. Metabolic workup history — whether a twenty-four-hour urine collection has been performed, what it showed, and whether the patient is currently on preventive medication such as potassium citrate, thiazide diuretics, or allopurinol — tells the urologist whether the stone disease is being actively managed or has been treated reactively with each episode.

Pelvic floor assessment: voiding dysfunction and pelvic pain across both sexes

Pelvic floor dysfunction is not a female-only concern, and urology intake forms need to assess it in both male and female patients. In women, the intake should capture stress urinary incontinence (leakage with coughing, sneezing, laughing, or exercise), urge incontinence (leakage associated with a sudden, intense need to void), mixed incontinence, pelvic organ prolapse symptoms (vaginal bulging, pressure, or the sensation of something falling out), and the impact of these symptoms on daily activities and quality of life. Obstetric history is relevant — number of vaginal deliveries, use of forceps or vacuum, birth weights of the largest child, and whether the patient experienced perineal tearing — because vaginal delivery is the strongest risk factor for pelvic floor dysfunction, and the details of the deliveries predict the type and severity of the damage.

In men, pelvic floor dysfunction manifests differently but is equally important to capture at intake. Chronic pelvic pain syndrome, also classified as chronic prostatitis type III, is one of the most common urologic diagnoses in men under fifty, and it is frequently underdiagnosed because the intake form never asks about it. The form should capture perineal pain, suprapubic pain, testicular or penile pain, pain with ejaculation, pain with sitting, and whether the pain is constant or intermittent. Voiding dysfunction in men — hesitancy, post-void dribbling, the sensation of incomplete emptying, and the need to strain to initiate the stream — can reflect pelvic floor hypertonicity rather than prostatic obstruction, and distinguishing between the two at intake prevents unnecessary prostate interventions in men whose problem is actually muscular.

The overlap between urinary, sexual, and pain symptoms in pelvic floor dysfunction is precisely why these questions need to be on a single integrated intake form rather than scattered across separate questionnaires. A woman who reports urinary leakage during intercourse may not connect that symptom to the stress incontinence she experiences when exercising, and a man who reports pain with ejaculation may not realize that his post-void dribbling is part of the same pelvic floor dysfunction. The structured form draws these connections by placing related questions in proximity, prompting the patient to recognize symptom patterns they would not have identified on their own.

Navigating sensitivity: why the form itself is the intervention

Urology occupies a unique position among medical specialties because nearly every symptom category it covers — urinary function, sexual performance, incontinence, genital pain, infertility — carries social stigma that suppresses disclosure. Patients delay seeking care for erectile dysfunction for an average of two to three years after onset. Women with urinary incontinence often manage the condition with pads and lifestyle modifications for years before mentioning it to any physician. Men with pelvic pain frequently see multiple providers across multiple specialties before anyone asks the right questions. The structured intake form is not just a documentation tool in this context. It is the clinical intervention that breaks the disclosure barrier.

When a patient sees "How many times do you wake at night to urinate?" printed on a form with a graded response scale, the question is depersonalized. It is no longer the physician singling out the patient's embarrassing problem. It is a standard question that every patient in this practice answers, which means the patient's experience is normal enough to have its own checkbox. That normalization effect is measurable. Studies consistently show that patients disclose more symptoms on written questionnaires than in face-to-face interviews, particularly for symptoms related to sexual function and incontinence. The intake form captures what the conversation misses, and what it captures changes the diagnosis, the treatment plan, and the outcome.

Practices building or refining their patient documentation can browse the full catalog of healthcare intake forms to find templates structured for specialty-specific symptom capture, including the sensitive categories that drive urology practice.

Urology intake forms — built for urologic practice

Fillable PDF intake form and client questionnaire designed for urology practices. Urinary symptom scoring, sexual health screening, prostate cancer documentation, kidney stone history, pelvic floor assessment, and HIPAA-compliant patient intake — structured to normalize the most sensitive symptom categories in medicine.

Browse Healthcare Forms